RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
RNAi Therapeutics: To the Liver … and Beyond
By Michael Tattory|
2018-04-27T13:21:42-04:00
March 15th, 2018|News|Comments Off on RNAi Therapeutics: To the Liver … and Beyond